| 1 |
34773257 | A GLP-1/GLP-2 receptor dual agonist to treat NASH: Targeting the gut-liver axis and microbiome. | 2022 Jun |
1 |
| 2 |
34986353 | Intestinal Gpr17 deficiency improves glucose metabolism by promoting GLP-1 secretion. | 2022 Jan 4 |
1 |
| 3 |
35017714 | E4orf1-induced reduction in endogenous insulin level is independent of pancreas endocrine function. | 2022 May |
1 |
| 4 |
35088915 | A novel DPP-4 inhibitor Gramcyclin A attenuates cognitive deficits in APP/PS1/tau triple transgenic mice via enhancing brain GLP-1-dependent glucose uptake. | 2022 Mar |
2 |
| 5 |
35147704 | The Essential Role of Pancreatic α-Cells in Maternal Metabolic Adaptation to Pregnancy. | 2022 May 1 |
1 |
| 6 |
35202915 | Small-molecule albumin ligand modification to enhance the anti-diabetic ability of GLP-1 derivatives. | 2022 Apr |
1 |
| 7 |
35399667 | Dietary Medium-Chain Triglyceride Decanoate Affects Glucose Homeostasis Through GPR84-Mediated GLP-1 Secretion in Mice. | 2022 |
1 |
| 8 |
35421610 | Glucose inhibits glucagon secretion by decreasing [Ca2+]c and by reducing the efficacy of Ca2+ on exocytosis via somatostatin-dependent and independent mechanisms. | 2022 Jul |
4 |
| 9 |
35424534 | Thiazolidinedione derivatives as novel GPR120 agonists for the treatment of type 2 diabetes. | 2022 Feb 16 |
1 |
| 10 |
35439540 | Metabolic effects of combined glucagon receptor antagonism and glucagon-like peptide-1 receptor agonism in high fat fed mice. | 2022 Aug |
1 |
| 11 |
35456981 | Glucagon-like Peptide-1 Secretion Is Inhibited by Lysophosphatidic Acid. | 2022 Apr 9 |
1 |
| 12 |
35484823 | A GLP-1/glucagon (GCG)/CCK2 receptors tri-agonist provides new therapy for obesity and diabetes. | 2022 Apr 28 |
2 |
| 13 |
35571083 | Co-Crystal of Rosiglitazone With Berberine Ameliorates Hyperglycemia and Insulin Resistance Through the PI3K/AKT/TXNIP Pathway In Vivo and In Vitro. | 2022 |
1 |
| 14 |
32473615 | Display of quintuple glucagon-like peptide 1 (28-36) nonapeptide on Bacillus subtilis spore for oral administration in the treatment of type 2 diabetes. | 2021 Feb |
1 |
| 15 |
32790843 | Glucagonotropic and Glucagonostatic Effects of KATP Channel Closure and Potassium Depolarization. | 2021 Jan 1 |
3 |
| 16 |
33043402 | Paracrine regulation of somatostatin secretion by insulin and glucagon in mouse pancreatic islets. | 2021 Jan |
2 |
| 17 |
33239450 | Glucagon Resistance and Decreased Susceptibility to Diabetes in a Model of Chronic Hyperglucagonemia. | 2021 Feb |
1 |
| 18 |
33369112 | Glucose-induced cAMP elevation in β-cells involves amplification of constitutive and glucagon-activated GLP-1 receptor signalling. | 2021 Apr |
1 |
| 19 |
33405187 | A Rodent Model of Jejunal-Ileal Loop Bipartition (JILB): a Novel Malabsorptive Operation. | 2021 Mar |
1 |
| 20 |
33421947 | A novel GLP-1 and FGF21 dual agonist has therapeutic potential for diabetes and non-alcoholic steatohepatitis. | 2021 Jan |
1 |
| 21 |
33434183 | Antagonizing somatostatin receptor subtype 2 and 5 reduces blood glucose in a gut- and GLP-1R-dependent manner. | 2021 Feb 22 |
3 |
| 22 |
33434430 | Structure-Activity Relationship and Biological Investigation of SR18292 (16), a Suppressor of Glucagon-Induced Glucose Production. | 2021 Jan 28 |
2 |
| 23 |
33484949 | Free fatty acid receptor 4 inhibitory signaling in delta cells regulates islet hormone secretion in mice. | 2021 Mar |
1 |
| 24 |
33561965 | High β-Glucan Barley Supplementation Improves Glucose Tolerance by Increasing GLP-1 Secretion in Diet-Induced Obesity Mice. | 2021 Feb 6 |
1 |
| 25 |
33588950 | Mesenchymal stem cells modified by FGF21 and GLP1 ameliorate lipid metabolism while reducing blood glucose in type 2 diabetic mice. | 2021 Feb 15 |
2 |
| 26 |
33610858 | Genetic activation of α-cell glucokinase in mice causes enhanced glucose-suppression of glucagon secretion during normal and diabetic states. | 2021 Jul |
2 |
| 27 |
33627316 | Glucolipotoxicity and GLP-1 secretion. | 2021 Feb |
1 |
| 28 |
33636577 | Matrine, as a CaSR agonist promotes intestinal GLP-1 secretion and improves insulin resistance in diabetes mellitus. | 2021 Apr |
1 |
| 29 |
33641163 | The 14-3-3 protein YWHAB inhibits glucagon-induced hepatic gluconeogenesis through interacting with the glucagon receptor and FOXO1. | 2021 May |
1 |
| 30 |
33839150 | Insulin receptor substrate 1, but not IRS2, plays a dominant role in regulating pancreatic alpha cell function in mice. | 2021 Jan-Jun |
1 |
| 31 |
33911126 | Discovery, optimization, and evaluation of non-bile acid FXR/TGR5 dual agonists. | 2021 Apr 28 |
1 |
| 32 |
33957303 | Fasting Hormones Synergistically Induce Amino Acid Catabolism Genes to Promote Gluconeogenesis. | 2021 |
1 |
| 33 |
34002801 | Deleterious mutation V369M in the mouse GCGR gene causes abnormal plasma amino acid levels indicative of a possible liver-α-cell axis. | 2021 Jun 25 |
1 |
| 34 |
34054734 | Benefits of Sustained Upregulated Unimolecular GLP-1 and CCK Receptor Signalling in Obesity-Diabetes. | 2021 |
1 |
| 35 |
34095876 | GIPR antagonist antibodies conjugated to GLP-1 peptide are bispecific molecules that decrease weight in obese mice and monkeys. | 2021 May 18 |
2 |
| 36 |
34118477 | KATP channel blockers control glucagon secretion by distinct mechanisms: A direct stimulation of α-cells involving a [Ca2+]c rise and an indirect inhibition mediated by somatostatin. | 2021 Nov |
1 |
| 37 |
34122340 | The Insulin Response to Oral Glucose in GIP and GLP-1 Receptor Knockout Mice: Review of the Literature and Stepwise Glucose Dose Response Studies in Female Mice. | 2021 |
3 |
| 38 |
34168616 | Gastrointestinal Distension by Pectin-Containing Carbonated Solution Suppresses Food Intake and Enhances Glucose Tolerance via GLP-1 Secretion and Vagal Afferent Activation. | 2021 |
1 |
| 39 |
34168617 | Impact of Incretin Hormone Receptors on Insulin-Independent Glucose Disposal in Model Experiments in Mice. | 2021 |
3 |
| 40 |
34221868 | Mitochondrial protein IF1 is a potential regulator of glucagon-like peptide (GLP-1) secretion function of the mouse intestine. | 2021 Jun |
3 |
| 41 |
34246804 | β-Cell pre-mir-21 induces dysfunction and loss of cellular identity by targeting transforming growth factor beta 2 (Tgfb2) and Smad family member 2 (Smad2) mRNAs. | 2021 Nov |
1 |
| 42 |
34280305 | Glucose-Fueled Peptide Assembly: Glucagon Delivery via Enzymatic Actuation. | 2021 Aug 18 |
10 |
| 43 |
34284984 | A method for constructing GLP-1 overexpression intestinal organoids. | 2021 Jul 20 |
1 |
| 44 |
34356378 | Purification, Physicochemical Properties, and Antioxidant Activities of Two Low-Molecular-Weight Polysaccharides from Ganoderma leucocontextum Fruiting Bodies. | 2021 Jul 20 |
1 |
| 45 |
34444712 | Storage and Utilization of Glycogen by Mouse Liver during Adaptation to Nutritional Changes Are GLP-1 and PASK Dependent. | 2021 Jul 26 |
2 |
| 46 |
34520858 | L-cell Arntl is required for rhythmic glucagon-like peptide-1 secretion and maintenance of intestinal homeostasis. | 2021 Dec |
1 |
| 47 |
34547355 | Glucagon-like peptide-1 and beta cell glucose sensitivity - a glucose ramp study in mice. | 2021 Dec |
3 |
| 48 |
34572144 | Glucagon Potentiates Insulin Secretion Via β-Cell GCGR at Physiological Concentrations of Glucose. | 2021 Sep 21 |
1 |
| 49 |
34639136 | Lecithin Inclusion by α-Cyclodextrin Activates SREBP2 Signaling in the Gut and Ameliorates Postprandial Hyperglycemia. | 2021 Oct 6 |
2 |
| 50 |
34647524 | Hnf4g invalidation prevents diet-induced obesity via intestinal lipid malabsorption. | 2021 Nov 24 |
2 |